While probiotic supplementation cannot prevent asthma or wheezing, it may improve lung function and asthma control in infants, according to a new systematic review.
Both local Chinese and foreign infant nutrition brands in China are urged to “push hard on safety cues and messages” in light of the recent infant nutrition scandal happening in the country, according to an industry expert.
The standard of nutritional clinical research in APAC has improved by “leaps and bounds” in recent years, but researchers still need to take note of pitfalls such as biased judgements because strong science provides the cornerstone of commercially successful...
Ayurvedic supplement and FMCG giant Dabur India is conducting a three-month clinical trial to test if its chyawanprash formula could help prevent healthy individuals from contracting COVID-19.
Researchers from East Asia are urging more research and clinical studies of the Japanese herbal medicine, Kampo, as a treatment for frailty, as part of a push to increase awareness in global markets.
Japan’s Consumer Affairs Agency (CAA) has approved 2,887 products under the food with function claim (FFC) since its introduction in 2015 – but only 1325 are currently available on the market.
New Zealand direct-selling company About Health has added a multi-ingredient nicotinamide riboside (NR)-based product to its existing range of healthy ageing dietary supplements.
The top three purchase criteria for dietary supplements among Chinese consumers RE product quality (79%), ingredient list (60%) and quality assurance seal (53%), according to data from the United States Pharmacopeia (USP).
Australia’s Renovatio Bioscience has developed a new product that claims to strengthen the immune system using a combination of activated phenolics, quercetin, and sunflower extract.
A report from Australian regulator the Therapeutic Goods Administration (TGA) found that the percentage of health supplements that breached regulatory compliances in the second half of last year was less than that of 2018.
China is stepping up its compliance checks on food manufacturers and retailers to stem the unauthorised production and sales of special foods, including Foods for Special Medical Purpose (FSMPs).
China’s infant formula and supplement retailer, GOVKING Group, is promoting GoldMax – a New Zealand infant formula and supplement brand – through its ‘livestreaming incubator’.
Swiss firm Caviarlieri Limited is expanding further across Asia and Australia with its caviar-containing anti-ageing product, after seeing initial success in the Philippines and Thailand.
Japan’s food seasoning giant Ajinomoto is proposing amino acids like monosodium glutamate (MSG) as a candidate to help fight dementia and is working on a new range of seasoning products to help improve cognitive health.
Yangon-based FAME Pharmaceuticals is riding on the probiotics boom, with aggressive plans to expand its product range after introducing its first immunity-enhancement products.
Australian regulator, the Therapeutic Goods Administration (TGA) is reviewing recent reported cases of vitamin B6 intake and the possible side effect of peripheral neuropathy.
The body’s absorption of palmitoylethanolamide (PEA) – a healthy fatty acid – could be increased by 1.75 times using a novel dispersion technology, a human clinical trial has demonstrated.
Australian-based Homart Pharmaceuticals is launching three vitamin C products under the Toplife and Springleaf brands to tap on rising demand for immune-related products during the COVID-19 pandemic.
Australia’s e-commerce platform BuyNatural is working with local olive leaf specialist Wellgrove Health on a range of immunity-boosting supplements for the domestic and China markets to meet increased demand.
See April's 10 most read stories, including COVID-19's clinical trials research and what firms have done to cope with disruptions caused by the pandemic.
Supplements containing cannabidiol (CBD) should be made available in health foods stores in Australia, trade body Complementary Medicines Australia (CMA) has said as the country’s regulator reviews existing rules.
With social distancing in full effect, families have not only found themselves with a lot more time together, but a lot more time in front of their screens.
Companies and research institutes are having to put on hold or postpone their non-COVID-19 clinical trials due to movement control orders and public health resources prioritising the fight against COVID-19.
Japanese confectionery company Ezaki Glico has reported strong demand for its Mental Balance Chocolate GABA for Sleep, which carries a food with function claim (FFC).
Chromadex, the nicotinamide riboside (NR) specialist, has entered the beauty-from-within space with its new product exclusively launched in A.S. Watsons Hong Kong both offline and online.
In this round-up, we shine the spotlight on China's new cross-border e-commerce pilot zones and its implications for the supplement industry, India's task force to stem unsupported product claims against COVID-19, and more.
Singapore dietary supplement firm Avida Health will be launching a chocolate ball functional food targeted at improving kids’ immunity amid the current COVID-19 outbreak.
Molecular hydrogen (H2) could be a potential sports nutrition ingredient due to its antioxidant effect on exercise-induced oxidative stress, according to new findings.
A new blackcurrant anti-pollution 'smart drink' from New Zealand is to be created and assessed for its potential to combat air pollution and improve performance in athletes as part of an industry/academia collaboration.
Japan’s Taisho Pharmaceutical Holdings has released Japan’s first caffeine-free energy drink containing the botanical ingredient, enXtra, which has been clinically proven to improve alertness and focus up to five hours with or without caffeine.
Diabetic patients who adopt a nutrition therapy consisting of whey protein and monounsaturated fatty acids (MUFA) have lower fasting blood glucose during the one-month long Ramadan fasting period, a clinical trial in Malaysia has shown.
Hong Kong’s Aptorum Group is launching a dietary supplement (NLS-2 dioscorea opposita bioactive nutraceutical tablets) to improve symptoms related to menopausal transitions, such as osteoporosis.
New Zealand-based Vitality Wellness has expediated the launch of its immune health supplement made from blackcurrants to meet health demands arising from the COVID-19 outbreak.
Swisse says that its newly introduced hemp-based supplements and skincare range in the Australian market will play a crucial role in driving incremental growth for this year.
A group of researchers from the National University of Singapore (NUS) has developed what they believe is the first probiotic drink made from unsold loaves of bread and has now filed a patent for their creation.
Dietary supplement companies are finding new ways to boost the efficacy of their eye health products, with astaxanthin cited as one of the hottest ingredients.
A curcumin and artemisinin-based oral spray has been proposed as a treatment for COVID-19 patients and a clinical trial will be conducted, ASX-listed phytocannabinoid firm MGC Pharmaceuticals has revealed.
China’s addition of 46 cross-border e-commerce (CBEC) pilot zones will lead to the further influx of imported dietary supplements, with the healthy competition between local and imported goods helping to raise the bar for China’s domestic industry, according...
Optibiotix says sales of its flagship weight management product, Optibiome, soared by more than 2500% year-on-year, with Australia the latest market in its sights as part of its ambitious expansion plans.
Researchers from Asia, the Middle East, and the West are now trialling omega-3, honey, and even potato resistant starch, on top of vitamins and zinc, as they race to find products that could contribute to the fight against COVID-19 and its symptoms.
Regional collaboration to collect ‘big data’ spanning diets, epigenetics, health backgrounds, and the microbiome will be essential to drive personal and precision nutrition in East Asia, according to industry heavyweight Dr Wang Chin-Kun, who is the subject...